These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 16504680)

  • 1. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
    Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
    Gonzalez Molina M; Morales JM; Marcen R; Campistol JM; Oppenheimer F; Serón D; Gil-Vernet S; Capdevila L; Andrés A; Lampreave I; Del Castillo D; Cabello M; Burgos D; Valdés F; Anaya F; Escuín F; Arias M; Pallardó L; Bustamante J
    Transplant Proc; 2007 Sep; 39(7):2167-9. PubMed ID: 17889126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus decreases tubular phosphate wasting in renal allograft recipients.
    Falkiewicz K; Nahaczewska W; Boratynska M; Owczarek H; Klinger M; Kaminska D; Wozniak M; Szepietowski T; Patrzalek D
    Transplant Proc; 2003 Sep; 35(6):2213-5. PubMed ID: 14529892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching immunosuppression from cyclosporine to tacrolimus improves long-term kidney function: a 6-year study.
    Hohage H; Welling U; Zeh M; Gerhardt U; Suwelack B
    Transplant Proc; 2005 May; 37(4):1898-9. PubMed ID: 15919497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better renal function with enhanced immunosuppression and protocol biopsies after kidney transplantation in children.
    Seikku P; Krogerus L; Jalanko H; Holmberg C
    Pediatr Transplant; 2005 Dec; 9(6):754-62. PubMed ID: 16269047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO
    Transplant Proc; 2009; 41(6):2659-63. PubMed ID: 19715995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial.
    Franz S; Regeniter A; Hopfer H; Mihatsch M; Dickenmann M
    Am J Kidney Dis; 2010 Feb; 55(2):335-43. PubMed ID: 19926370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A; Arlen D; Barrett B; Boucher A; Cardella C; Cockfield SM; Rush D; Paraskevas S; Shapiro J; Shoker A; Yilmaz S; Zaltzman JS; Kiberd B
    Transplantation; 2008 Oct; 86(7):953-60. PubMed ID: 18852662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T;
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR; Lin CC; Lian JD
    Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
    Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
    Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results and complications after living related kidney transplantation in Hungary: 30 years' experience.
    Dallos G; Hídvégi M; Kósa G; Kóbori L; Alföldy F; Perner F; Járay J
    Transplant Proc; 2010; 42(6):2312-4. PubMed ID: 20692470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of and predictors for tacrolimus rescue therapy among renal transplant patients under cyclosporine-based immunosuppression.
    Hu RH; Lee CY; Tsai MK; Lee PH
    Transplant Proc; 2004 Sep; 36(7):2092-5. PubMed ID: 15518757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
    Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete switch to everolimus in long-term kidney transplants: evolution of the renal function.
    Fernández A; Marcén R; Galeano C; Caldés S; Amezquita Y; Villafruela J; Pascual J; Burgos J; Rodríguez-Mendiola N; Ortuño J
    Transplant Proc; 2009; 41(6):2345-7. PubMed ID: 19715915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of donor source on renal allograft function in children on triple immunosuppression.
    Laine J; Fyhrquist F; Holmberg C
    Nephrol Dial Transplant; 1994; 9(10):1468-73. PubMed ID: 7816262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.